Sichuan Kelun-Biotech Biopharmaceutical (SEHK:06990) H2 2025 Earnings call March 23, 2026 08:00 AM ET Company ParticipantsDing Nanchao - Deputy General Manager and Chief Marketing OfficerGe Junyou - President and CEOJinbo Zhang - Director of the Analytical DepartmentMatthew Culley - Portfolio ManagerWei Chen - Deputy General Manager and VP of Molecule R&DXiangyang Tan - Chief Scientific OfficerXiao Ping Jin - Chief Medical OfficerZe Jian Zhou - CFOConference Call ParticipantsShen Ziyi - Equity Research Anal ...

Sichuan Kelun-Biotech Biopharmaceutical (SEHK:06990) H2 2025 Earnings call March 23, 2026 08:00 AM ET Speaker6Thank you for joining Kelun-Biotech earnings call for 2025 annual results. Within next one hour, we are going to present our business and financial performance in 2025, followed by a Q&A session. Management presentation will be conducted in Mandarin with English interpretation. Please switch to English channel if you prefer English language. This conference call will be recorded and provided to Kelu ...